Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
On April 25, 2016, long-awaited federal rules putting regulation of all tobacco products, including e-cigarettes, vaporizers, and other electronic nicotine delivery systems (ENDS), under the authority of the U.S. Food and Drug Administration (FDA) became final.
Until now, ENDS, or products that use liquid nicotine, as well as varying compositions of flavorings, propylene glycol, glycerin, and other ingredients, have been largely unsupervised by the government.
The FDA rules for electronic nicotine delivery systems (ENDS) prohibit selling “covered tobacco products” to people younger than 18, and buyers must show photo ID.
Under the rules, the FDA would have to approve all tobacco products not currently regulated that hit stores after February 2007, and e-cigarette manufacturers will be required to allow government review of how the devices are made before they can be sold to adults in the U.S. The federal rules include other controls on tobacco products, including banning free samples, prohibiting vending machine sales, and requiring warning labels on packaging.
Manufacturers will also be required to disclose the ingredients in the liquid nicotine used in vaping.
Currently, the disclosure of what is contained in that liquid is not required, and dangerous chemicals such as Diacetyl and Acetyl Propionyl, flavorings associated with lung disease, have been found in e-cigarette juice.
E-cigarettes commonly contain flavorings that make them more popular with youth, including cotton candy, bubble gum, and chocolate, but these flavorings may cause respiratory disease and are known to be dangerous when inhaled.
Use of these electronic nicotine delivery systems has been growing rapidly in the last few years, particularly among young people.
According to the Center for Disease Control and Prevention (CDC), three million middle and high school students are current users of e-cigarettes, up from 2.5 million in 2014.
Previous research has shown that teenagers who try e-cigarettes may be more than twice as likely to try conventional cigarettes as opposed to adolescents who have never tried the devices.
Diacetyl, a flavoring chemical linked to cases of severe respiratory disease referred to as “popcorn lung disease” and the subject of a number of diacetyl lawsuits was found in more than 75% of flavored electronic cigarettes, according to a Harvard Chan School of Public Health study.
More research is needed to determine how the heating mechanism in E-cigarettes would effect e-juice containing Diacetyl.
Until such research is complete, consumers need to be warned that a dangerous substance that causes an irreversible disease is in their e-cigarettes.
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Fresenius Kabi USA, LLC has announced a corrective Class I recall of an infusion pump software, LVP Software, that runs on the Ivenix Infusion System (IIS). Initiated by the firm on March 7, 2024, the action comes after multiple software anomalies were identified and found
According to the FDA, 20-ounce packages of “King Kullen Broccoli Cutlets with Bread Crumbs and Parmesan” have been recalled by New Haven, Connecticut-based Gracie’s Kitchen due to the potential presence of undeclared sesame and wheat. Individuals who live with allergies to either allergen are advised
The FDA is warning consumers of a Class I recall of Boston Scientific’s Obsidio Comformable Embolic because the device has been shown to present a risk for increased bowel ischemia when used for lower GI (gastrointestinal) bleeding, or acute colonic bleeding. As a pre-mixed embolic